Skip to main content
. Author manuscript; available in PMC: 2014 Sep 11.
Published in final edited form as: Hypertens Res. 2011 Sep 22;34(12):1257–1262. doi: 10.1038/hr.2011.110

Figure 3.

Figure 3

Baroreflex sensitivity (BRS) in response to bradykinin potentiating nonapeptide (BPP)9α expressed as the ratio to baseline 2 h and after solitary tract nucleus (nTS) microinjection of d-Ala or HOE-140. Microinjection of BPP9α approximately doubled BRS and this effect was reversed by d-Ala back to baseline, but HOE-140 did not significantly alter the effect of the BPP9α.